Format

Send to

Choose Destination
Curr Pharm Des. 2011;17(1):21-6.

Critical determinants of cardiovascular risk in rheumatoid arthritis.

Author information

1
Department of Clinical Immunology and Rheumatology, Room F4-218, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands. r.j.bisoendial@amc.uva.nl

Abstract

Rheumatoid arthritis (RA), a prototypical immune-mediated inflammatory disease, is characterized by increased cardiovascular morbidity and mortality, independent from the established cardiovascular risk factors. The chronic inflammatory state, a hallmark of RA, is considered to be a driving force for accelerated atherogenesis. Concurrent conditions that expedite the atherosclerotic process in RA involve endothelial dysfunction, dyslipidemia and procoagulant changes. These facilitating states can be reversed by retraction of the systemic inflammatory activity. Consequently, aggressive control of disease activity has been suggested to be instrumental for cardiovascular risk reduction. In the present review, we focus on these critical determinant that promote premature atherosclerosis in RA.

PMID:
21226666
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center